Ebc Pharmaceuticals Private Limited

Ebc Pharmaceuticals Private Limited - chemicals in Thrissur, Kerala, India. FY 2026 financials and compliance.
CIN U24290KL2020PTC061105 Incorporated 10 January 2020 ROC Ernakulam HQ Thrissur, Kerala, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹2.12 Cr
▲ 50.00% YoY
EBITDA · FY 2025
*****
▲ 209.00% YoY
Net profit · FY 2025
*****
▲ 106.00% YoY
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Ebc Pharmaceuticals Private Limited

Data last updated: 12 March 2026

Ebc Pharmaceuticals Private Limited is a private limited company based in Thrissur, Kerala, India. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 10 January 2020, the company has been in operation for over 6 years.

Registered with ROC Ernakulam under CIN U24290KL2020PTC061105.

Capital: an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Pranop Kumar Cheriyambalathil and Kalarikkal Deepak Kumar.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Thrissur, Kerala.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.12 Cr, a growth of 50% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Ebc Pharmaceuticals Private Limited
CIN U24290KL2020PTC061105
Registration Number 061105
Incorporation Date 10 January 2020
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Kalarikkal Deepak Kumar Managing Director Pranop Kumar Cheriyambalathil Director Raja Gopala Menon Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Room No. 17/322 (51/1759) Netaji Road, Opp. Netaji Ground Aranattukara, Thrissur, Kerala, India – 680618
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Company report
Ebc Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ebc Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ebc Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Ebc Pharmaceuticals Private Limited

Ebc Pharmaceuticals Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading *********

Board of Directors of Ebc Pharmaceuticals Private Limited

Ebc Pharmaceuticals Private Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pranop Kumar Cheriyambalathil Director 11 Aug 2020 5 Years 11 Months Current
Kalarikkal Deepak Kumar Managing Director 10 Jan 2020 6 Years 6 Months Current
Raja Gopala Menon
Also directs: Beskyn Science Private Limited, Ylabs Scientific Private Limited
Director 24 Mar 2023 3 Years 3 Months Current
Rejeesh Ramesan Remesh Director 23 Mar 2022 4 Years 3 Months Current
View all directors

Financials of Ebc Pharmaceuticals Private Limited FY 2025 filings available

Ebc Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr (up 50% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹2.12 Cr ▲ 50%
Profit
***** ▲ 106%
EBITDA
***** ▲ 209%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of Ebc Pharmaceuticals Private Limited?

View Ebc Pharmaceuticals Private Limited's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings Ebc Pharmaceuticals Private Limited

Ebc Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Ebc Pharmaceuticals Private Limited

View historical data on people associated with Ebc Pharmaceuticals Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Ebc Pharmaceuticals Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Ebc Pharmaceuticals Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Ebc Pharmaceuticals Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Ebc Pharmaceuticals Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Ebc Pharmaceuticals Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Ebc Pharmaceuticals Private Limited

MSME Payment Delays by Ebc Pharmaceuticals Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Ebc Pharmaceuticals Private Limited

Subsidiaries & Group Companies of Ebc Pharmaceuticals Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ebc Pharmaceuticals Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Ebc Pharmaceuticals Private Limited

MCA Filings & Documents of Ebc Pharmaceuticals Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Ebc Pharmaceuticals Private Limited

Activity
30 Sep 2025
Ebc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Ebc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Directors
24 Mar 2023
Raja Gopala Menon was appointed as a Director on 24 Mar 2023 & has been associated with this company since 3 years 3 months.
Directors
23 Mar 2022
Rejeesh Ramesan Remesh was appointed as a Director on 23 Mar 2022 & has been associated with this company since 4 years 3 months.
Directors
11 Aug 2020
Pranop Kumar Cheriyambalathil was appointed as a Director on 11 Aug 2020 & has been associated with this company since 5 years 11 months.
Directors
10 Jan 2020
Kalarikkal Deepak Kumar was appointed as a Managing Director on 10 Jan 2020 & has been associated with this company since 6 years 6 months.

Frequently Asked Questions about Ebc Pharmaceuticals Private Limited

Ebc Pharmaceuticals Private Limited is an active private limited company in the chemicals sector based in Thrissur, Kerala, India. It was incorporated on 10 January 2020 (6+ years old) and is registered under CIN U24290KL2020PTC061105.

Ebc Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr for FY 2025 (up 50.00% YoY).

The current directors of Ebc Pharmaceuticals Private Limited are:

The primary industry of Ebc Pharmaceuticals Private Limited is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.

Ebc Pharmaceuticals Private Limited can be reached at the registered office: Room No. 17322 511759 Netaji Road, Opp. Netaji Ground Aranattukara, Thrissur, Kerala, India – 680618.

The authorised capital is ₹15 Lakh, and the paid-up capital is ₹15 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available